FDA.reportPublic FDA data

Ultravist

Product NDC
50419-344
11-digit product format
504190344
Labeler code
50419
Product ID
50419-344_4314fa34-edbc-44f3-b40b-277c6fbd2ab0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
iopromide
Dosage form
INJECTION
Route
INTRA-ARTERIAL; INTRAVENOUS
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Application
NDA020220
Marketing category
NDA
Marketing start
2009-12-30
Substance
IOPROMIDE
Active strength
300 mg/mL
Pharmacologic classes
Radiographic Contrast Agent [EPC], X-Ray Contrast Activity [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ultravist
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
IOPROMIDE300 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii712BAC33MZ

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
77dc03a4-fbfc-e6a3-fe95-285bbae40d75Product name220250814
777d68c6-a5ab-e06c-d314-677b0b9af0c8Product name220240508
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50419-344-052024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-072024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-102024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-122024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-152024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-212024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-232024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-322024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-412024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-432024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-482024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-582024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-652024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-912024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-972024-08-21C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-052024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-072024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-102024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-122024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-152024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-212024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-232024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-322024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-412024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-432024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-482024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-582024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-652024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-912024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-972024-07-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-052024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-072024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-102024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-122024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-152024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-212024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-232024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-322024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-412024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-432024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-482024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-582024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-652024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-912024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995
50419-344-972024-01-30C16284748780-11030e365-08f6-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection. ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial use Initial U.S. Approval: 1995

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50419-344-05Ultravist10 in 1 CARTONINJECTION1025
50419-344-05Ultravist50 mL in 1 VIAL, GLASSINJECTION5025
50419-344-07Ultravist75 mL in 1 VIAL, GLASSINJECTION7525
50419-344-07Ultravist10 in 1 CARTONINJECTION1025
50419-344-10Ultravist100 mL in 1 VIAL, GLASSINJECTION10025
50419-344-10Ultravist10 in 1 CARTONINJECTION1025
50419-344-12Ultravist10 in 1 CARTONINJECTION1025
50419-344-12Ultravist125 mL in 1 VIAL, GLASSINJECTION12525
50419-344-15Ultravist150 mL in 1 VIAL, GLASSINJECTION15025
50419-344-15Ultravist10 in 1 CARTONINJECTION1025
50419-344-21Ultravist10 in 1 PACKAGEINJECTION1025
50419-344-21Ultravist200 mL in 1 BOTTLEINJECTION20025
50419-344-23Ultravist200 mL in 1 BOTTLEINJECTION20025
50419-344-23Ultravist10 in 1 PACKAGEINJECTION1025
50419-344-32Ultravist500 mL in 1 BOTTLEINJECTION50025
50419-344-32Ultravist8 in 1 PACKAGEINJECTION825
50419-344-41Ultravist50 mL in 1 VIAL, GLASSINJECTION5025
50419-344-41Ultravist10 in 1 CARTONINJECTION1025
50419-344-43Ultravist10 in 1 CARTONINJECTION1025
50419-344-43Ultravist100 mL in 1 VIAL, GLASSINJECTION10025
50419-344-48Ultravist500 mL in 1 BOTTLEINJECTION50025
50419-344-48Ultravist8 in 1 PACKAGEINJECTION825
50419-344-58Ultravist8 in 1 PACKAGEINJECTION825
50419-344-58Ultravist500 mL in 1 BOTTLEINJECTION50025
50419-344-65Ultravist8 in 1 PACKAGEINJECTION825
50419-344-65Ultravist500 mL in 1 BOTTLEINJECTION50025
50419-344-91Ultravist100 mL in 1 VIAL, GLASSINJECTION10025
50419-344-91Ultravist10 in 1 CARTONINJECTION1025
50419-344-97Ultravist500 mL in 1 BOTTLEINJECTION50025
50419-344-97Ultravist8 in 1 PACKAGEINJECTION825
50419-344-21Ultravist200 mL in 1 BOTTLEINJECTION20022
50419-344-21Ultravist10 in 1 PACKAGEINJECTION1022
50419-344-32Ultravist8 in 1 PACKAGEINJECTION822
50419-344-32Ultravist500 mL in 1 BOTTLEINJECTION50022
50419-344-48Ultravist500 mL in 1 BOTTLEINJECTION50022
50419-344-48Ultravist8 in 1 PACKAGEINJECTION822
50419-344-58Ultravist8 in 1 PACKAGEINJECTION822
50419-344-58Ultravist500 mL in 1 BOTTLEINJECTION50022
50419-344-97Ultravist8 in 1 PACKAGEINJECTION822
50419-344-97Ultravist500 mL in 1 BOTTLEINJECTION50022
50419-344-23Ultravist200 mL in 1 BOTTLEINJECTION2008
50419-344-23Ultravist10 in 1 PACKAGEINJECTION108
50419-344-65Ultravist8 in 1 PACKAGEINJECTION88
50419-344-65Ultravist500 mL in 1 BOTTLEINJECTION5008

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50419-344-05ML - Milliliter50419-34457f32bd3-c47f-4c25-a235-341a50a11bcd12012-07-24
50419-344-07ML - Milliliter50419-34485ddc566-bdfe-4b67-8719-b953fe4a3c7812012-07-24
50419-344-10ML - Milliliter50419-3446f8e7f60-d4b3-405b-b6a5-d98bf00f3e1012012-07-24
50419-344-12ML - Milliliter50419-344216642fe-3785-457c-aed4-2f2cd4eac83012012-07-24
50419-344-15ML - Milliliter50419-34436e76849-82f8-4090-babd-889a2b26126e12012-07-24
50419-344-21ML - Milliliter50419-34403cd2c50-0a4a-4103-ba05-9e43ec3442b912012-07-24
50419-344-23ML - Milliliter50419-344173844e9-9eef-415d-a7c1-80679998de2512025-09-12
50419-344-50ML - Milliliter50419-344f1089d88-4651-4582-85b9-198c6d029cd212013-03-03
50419-344-58ML - Milliliter50419-34444fd3102-a1f7-49a4-b644-72ae59d0346a12012-07-24
50419-344-65ML - Milliliter50419-344936a0d60-04a8-4c95-b108-cb89bf6dfd7a12025-09-12

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
IOPROMIDEACTIVE INGREDIENT712BAC33MZULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8
IOPROMIDEACTIVE MOIETY712BAC33MZULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8
EDETATE CALCIUM DISODIUMINACTIVE INGREDIENT25IH6R4SGFULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8
TROMETHAMINEINACTIVE INGREDIENT023C2WHX2VULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8
IOPROMIDEACTIVE INGREDIENT712BAC33MZULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]5
IOPROMIDEACTIVE MOIETY712BAC33MZULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]5
EDETATE CALCIUM DISODIUMINACTIVE INGREDIENT25IH6R4SGFULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]5
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CBULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]5
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32IULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]5
TROMETHAMINEINACTIVE INGREDIENT023C2WHX2VULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50419-344ULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]22Current NDC, Legacy NDC, 10 package rows20230515_d96a7883-d160-40a1-bdbd-2e8d7877cd18.zip
50419-344ULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]22Current NDC, Legacy NDC, 30 package rows20240822_df917c3a-59a2-4ed1-8470-8a5394c73325.zip
50419-344ULTRAVIST (IOPROMIDE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.]8Current NDC, Legacy NDC, 4 package rows20230515_65647318-27e4-4f37-bd68-50eea52d6c5b.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50419-344-055041903440510 VIAL, GLASS in 1 CARTON (50419-344-05) / 50 mL in 1 VIAL, GLASS2009-12-300000-00-00NoNoCurrent
50419-344-075041903440775 mL in 1 VIAL, GLASS75 mlHistorical
50419-344-105041903441010 VIAL, GLASS in 1 CARTON (50419-344-10) / 100 mL in 1 VIAL, GLASS2009-12-300000-00-00NoNoCurrent
50419-344-125041903441210 VIAL, GLASS in 1 CARTON (50419-344-12) / 125 mL in 1 VIAL, GLASS2009-12-300000-00-00NoNoCurrent
50419-344-155041903441510 VIAL, GLASS in 1 CARTON (50419-344-15) / 150 mL in 1 VIAL, GLASS2009-12-300000-00-00NoNoCurrent
50419-344-215041903442110 BOTTLE in 1 PACKAGE (50419-344-21) / 200 mL in 1 BOTTLE10 bottle2009-12-300000-00-00NoNoCurrent
50419-344-235041903442310 BOTTLE in 1 PACKAGE (50419-344-23) / 200 mL in 1 BOTTLE10 bottle2018-05-040000-00-00NoNoCurrent
50419-344-32504190344328 BOTTLE in 1 PACKAGE (50419-344-32) / 500 mL in 1 BOTTLE8 bottle2015-10-110000-00-00NoNoCurrent
50419-344-415041903444110 VIAL, GLASS in 1 CARTON (50419-344-41) > 50 mL in 1 VIAL, GLASS2009-12-300000-00-00NoNoCurrent
50419-344-435041903444310 VIAL, GLASS in 1 CARTON (50419-344-43) > 100 mL in 1 VIAL, GLASS2009-12-300000-00-00NoNoCurrent
50419-344-48504190344488 BOTTLE in 1 PACKAGE (50419-344-48) > 500 mL in 1 BOTTLE8 bottle2009-12-300000-00-00NoNoCurrent
50419-344-58504190344588 BOTTLE in 1 PACKAGE (50419-344-58) / 500 mL in 1 BOTTLE8 bottle2009-12-300000-00-00NoNoCurrent
50419-344-65504190344658 BOTTLE in 1 PACKAGE (50419-344-65) / 500 mL in 1 BOTTLE8 bottle2018-05-040000-00-00NoNoCurrent
50419-344-915041903449110 VIAL, GLASS in 1 CARTON (50419-344-91) / 100 mL in 1 VIAL, GLASS2016-10-110000-00-00NoNoCurrent
50419-344-97504190344978 BOTTLE in 1 PACKAGE (50419-344-97) / 500 mL in 1 BOTTLE8 bottle2016-10-110000-00-00NoNoCurrent